APA (7th ed.) Citation

Liang, Y., Yang, Y., Zou, C., Liu, L., Jiao, Y., Wang, Y., . . . Luo, X. (2025). Safety and efficacy of laronidase in Chinese patients with mucopolysaccharidosis type I: A phase IV, single-arm, open-label, multicenter study. Orphanet Journal of Rare Diseases, 20(1), 1. https://doi.org/10.1186/s13023-025-04056-w

Chicago Style (17th ed.) Citation

Liang, Yan, Yan-Ling Yang, Chao-Chun Zou, Li Liu, Ying Jiao, Yu Wang, Xin Liu, and Xiao-Ping Luo. "Safety and Efficacy of Laronidase in Chinese Patients with Mucopolysaccharidosis Type I: A Phase IV, Single-arm, Open-label, Multicenter Study." Orphanet Journal of Rare Diseases 20, no. 1 (2025): 1. https://doi.org/10.1186/s13023-025-04056-w.

MLA (9th ed.) Citation

Liang, Yan, et al. "Safety and Efficacy of Laronidase in Chinese Patients with Mucopolysaccharidosis Type I: A Phase IV, Single-arm, Open-label, Multicenter Study." Orphanet Journal of Rare Diseases, vol. 20, no. 1, 2025, p. 1, https://doi.org/10.1186/s13023-025-04056-w.